Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

886 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prevalence of prescription opioid use during pregnancy in eight US health plans during 2001-2014.
Pocobelli G, Dublin S, Bobb JF, Albertson-Junkans L, Andrade S, Cheetham TC, Salgado G, Griffin MR, Raebel MA, Smith D, Li DK, Pawloski PA, Toh S, Taylor L, Hua W, Horn P, Trinidad JP, Boudreau DM. Pocobelli G, et al. Among authors: toh s. Pharmacoepidemiol Drug Saf. 2021 Nov;30(11):1541-1550. doi: 10.1002/pds.5312. Epub 2021 Jul 7. Pharmacoepidemiol Drug Saf. 2021. PMID: 34169607
Medication Exposure in Pregnancy Risk Evaluation Program.
Andrade SE, Davis RL, Cheetham TC, Cooper WO, Li DK, Amini T, Beaton SJ, Dublin S, Hammad TA, Pawloski PA, Raebel MA, Smith DH, Staffa JA, Toh S, Dashevsky I, Haffenreffer K, Lane K, Platt R, Scott PE. Andrade SE, et al. Among authors: toh s. Matern Child Health J. 2012 Oct;16(7):1349-54. doi: 10.1007/s10995-011-0902-x. Matern Child Health J. 2012. PMID: 22002179 Free PMC article.
Prospective surveillance pilot of rivaroxaban safety within the US Food and Drug Administration Sentinel System.
Chrischilles EA, Gagne JJ, Fireman B, Nelson J, Toh S, Shoaibi A, Reichman ME, Wang S, Nguyen M, Zhang R, Izem R, Goulding MR, Southworth MR, Graham DJ, Fuller C, Katcoff H, Woodworth T, Rogers C, Saliga R, Lin ND, McMahill-Walraven CN, Nair VP, Haynes K, Carnahan RM. Chrischilles EA, et al. Among authors: toh s. Pharmacoepidemiol Drug Saf. 2018 Mar;27(3):263-271. doi: 10.1002/pds.4375. Epub 2018 Jan 10. Pharmacoepidemiol Drug Saf. 2018. PMID: 29318683
Sequential surveillance for drug safety in a regulatory environment.
Martin D, Gagne JJ, Gruber S, Izem R, Nelson JC, Nguyen MD, Ouellet-Hellstrom R, Schneeweiss S, Toh S, Walker AM. Martin D, et al. Among authors: toh s. Pharmacoepidemiol Drug Saf. 2018 Jul;27(7):707-712. doi: 10.1002/pds.4407. Epub 2018 Mar 5. Pharmacoepidemiol Drug Saf. 2018. PMID: 29504168 No abstract available.
Utilization of drugs with pregnancy exposure registries during pregnancy.
Illoh OA, Toh S, Andrade SE, Hampp C, Sahin L, Gelperin K, Taylor L, Bird ST. Illoh OA, et al. Among authors: toh s. Pharmacoepidemiol Drug Saf. 2018 Jun;27(6):604-611. doi: 10.1002/pds.4409. Epub 2018 Mar 8. Pharmacoepidemiol Drug Saf. 2018. PMID: 29516585
886 results